Stockholm3 test before MRI for prostate cancer detection
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether a new blood test (Stockholm3) helps predict prostate cancer findings on MRI. It enrolls men already scheduled for an MRI to screen for prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between ages 40 and 80.
- You are already scheduled to have an MRI for prostate cancer screening.
- Your most recent PSA test was 1.5 ng/mL or higher.
- You have never been diagnosed with prostate cancer or are not on active surveillance for it.
- You have not had a digital rectal exam within 5 days before the blood draw.
- You have not had any invasive urologic procedure (like a prostate surgery or bladder scope) in the last 3 months.
- You have not started a new treatment for an enlarged prostate in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a blood test called Stockholm3 can help monitor prostate cancer in men who are already on active surveillance. It may help doctors decide if a biopsy is needed.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This study enrolls men who may have prostate cancer but do not yet have a diagnosis. It uses prostate MRI along with blood and urine tests to see if specific signals can help identify prostate cancer sooner.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
This study tests a new MRI platform to better identify prostate issues before a biopsy. It is for people with elevated PSA whose doctor is considering a biopsy.
This study is testing an approach to find prostate cancer earlier in men who may be at higher risk. If you fit the criteria, you may get an mpMRI scan before undergoing a prostate biopsy to check for cancer.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.